Randomized Phase II Window Trial of Two Schedules of Irinotecan With Vincristine in Patients With First Relapse or Progression of Rhabdomyosarcoma: A Report From the Children's Oncology Group

PURPOSE: To compare response rates for two schedules of irinotecan with vincristine in patients with rhabdomyosarcoma at first relapse or disease progression. PATIENTS AND METHODS: Patients with first relapse or progression of rhabdomyosarcoma and an unfavorable prognosis were randomly assigned to o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mascarenhas, Leo, Lyden, Elizabeth R., Breitfeld, Philip P., Walterhouse, David O., Donaldson, Sarah S., Paidas, Charles N., Parham, David M., Anderson, James R., Meyer, William H., Hawkins, Douglas S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2010
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2974343/
https://ncbi.nlm.nih.gov/pubmed/20837952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.29.7390
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados